Goldman Sachs Group, Inc. (The) set a €97.00 ($115.48) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report issued on Tuesday. The brokerage currently has a buy rating on the stock.

FME has been the topic of a number of other research reports. Citigroup Inc. set a €92.00 ($109.52) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Tuesday, August 8th. Deutsche Bank AG set a €85.00 ($101.19) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Wednesday, August 2nd. Kepler Capital Markets set a €95.00 ($113.10) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Wednesday, August 2nd. J P Morgan Chase & Co set a €106.40 ($126.67) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research report on Tuesday, June 13th. Finally, Commerzbank Ag set a €88.00 ($104.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research report on Tuesday, August 1st. One research analyst has rated the stock with a sell rating, nine have given a hold rating and ten have assigned a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of €88.39 ($105.22).

Shares of Fresenius Medical Care AG & Co. KGaA (FME) opened at 81.833 on Tuesday. The stock has a market cap of €25.11 billion and a PE ratio of 21.102. The firm’s 50-day moving average is €79.29 and its 200 day moving average is €81.66. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €70.82 and a 12 month high of €89.07.

WARNING: “Goldman Sachs Group, Inc. (The) Reiterates “€97.00” Price Target for Fresenius Medical Care AG & Co. KGaA (FME)” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/09/21/goldman-sachs-group-inc-the-reiterates-97-00-price-target-for-fresenius-medical-care-ag-co-kgaa-fme.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.